Published on 17 Nov 2023 on Simply Wall St. via Yahoo Finance

Rockwell Medical, Inc. (NASDAQ:RMTI): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Rockwell Medical, Inc.'s (NASDAQ:RMTI) business as it appears the company may be on the cusp of a considerable accomplishment. Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The US$59m market-cap company posted a loss in its most recent financial year of US$19m and a latest trailing-twelve-month loss of US$9.3m shrinking the gap between loss and breakeven. The most pressing concern for investors is Rockwell Medical's path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

View our latest analysis for Rockwell Medical

According to the 2 industry analysts covering Rockwell Medical, the consensus is that breakeven is near. They expect the company to post a final loss in 2024, before turning a profit of US$1.5m in 2025. The company is therefore projected to breakeven around 2 years from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 83% is expected, which is extremely buoyant. Should the business grow at a slower rate, it will become profitable at a later date than expected.